Otsuka tops Vera Therapeutics in kidney disease study showdown

What's new in pharma

June 6, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Otsuka tops Vera Therapeutics in kidney disease study showdown The companies are developing drugs for a kidney condition called IgA nephropathy, aiming to slow or halt the deterioration of kidney function. By Adam Feuerstein STAT+ | FDA reassures rare disease advocates that 'being flexible' is plan for gene therapy Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals. By Jason Mast STAT+ | Senate GOP eyes Medicare Advantage reforms as a way to pay for tax cuts Senate Republicans eye crackdown on Medicare Advantage upcoding as a way to finance tax cuts in Trump's "Big Beautiful Bill." By John Wilkerson Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser